We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+3.11%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$292M
AUM Growth
+$17.7M
Cap. Flow
+$28.8M
Cap. Flow %
9.86%
Top 10 Hldgs %
37.34%
Holding
390
New
29
Increased
31
Reduced
89
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Miscellaneous 16.47%
3 Healthcare 13.08%
4 Consumer Staples 11.79%
5 Financials 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
26
GE Aerospace
GE
$355B
$3.56M 1.22%
23,487
-558
-2% -$81.1K
ADP icon
27
Automatic Data Processing
ADP
$114B
$3.33M 1.14%
32,381
-150
-0.5% -$14K
WLY icon
28
John Wiley & Sons Class A
WLY
$2.73B
$3.13M 1.07%
57,445
-850
-1% -$45.3K
SYK icon
29
Stryker
SYK
$127B
$2.8M 0.96%
23,370
-605
-3% -$69.6K
WFC.PRJ.CL
30
DELISTED
Wells Fargo & Company
WFC.PRJ.CL
$2.8M 0.96%
+105,850
New +$2.83M
FFIV icon
31
F5
FFIV
$22.3B
$2.64M 0.9%
18,225
-30
-0.2% -$4.06K
DD
32
DELISTED
Du Pont De Nemours E I
DD
$2.6M 0.89%
35,491
-1,900
-5% -$135K
TRP icon
33
TC Energy
TRP
$64.4B
$2.57M 0.88%
56,961
-300
-0.5% -$13.6K
MRK icon
34
Merck
MRK
$366B
$2.42M 0.83%
43,078
-625
-1% -$36.6K
TD icon
35
Toronto Dominion Bank
TD
$199B
$2.32M 0.8%
47,036
BIIB icon
36
Biogen
BIIB
$32.3B
$2.23M 0.76%
7,875
-40
-0.5% -$11.9K
USB.PRM
37
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
$2.08M 0.71%
73,625
+9,600
+15% +$277K
CELG
38
DELISTED
Celgene Corp
CELG
$2.08M 0.71%
17,940
+105
+0.6% +$11.7K
TFX icon
39
Teleflex
TFX
$5.92B
$2.04M 0.7%
12,684
-250
-2% -$38.9K
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.99M 0.68%
12,185
-100
-0.8% -$15.4K
KO icon
41
Coca-Cola
KO
$386B
$1.97M 0.67%
47,487
SFE
42
DELISTED
Safeguard Scientifics, Inc.
SFE
$1.85M 0.64%
137,916
-37,150
-21% -$458K
T icon
43
AT&T
T
$178B
$1.75M 0.6%
54,586
-2,648
-5% -$78.1K
MSFT icon
44
Microsoft
MSFT
$3.81T
$1.73M 0.59%
27,757
+2
+0% +$120
LQD icon
45
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
$1.62M 0.56%
13,860
IMO icon
46
Imperial Oil
IMO
$63.1B
$1.6M 0.55%
46,160
-3,200
-6% -$107K
MKC icon
47
McCormick & Company Non-Voting
MKC
$14.9B
$1.54M 0.53%
32,920
KEY.PRH.CL
48
DELISTED
KeyCorp
KEY.PRH.CL
$1.41M 0.48%
55,163
+45,262
+457% +$1.16M
RTX icon
49
RTX Corp
RTX
$285B
$1.39M 0.48%
20,142
+1,033
+5% +$68.5K
VNO.PRG.CL
50
DELISTED
Vornado Realty Trust
VNO.PRG.CL
$1.24M 0.42%
49,225
+2,600
+6% +$66.1K

Similar funds

American Research & Management Company's Q4 2016 Portfolio in Review

As of Q4 2016, American Research & Management Company held 390 positions worth $292M, up 6.4% from $274M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

American Research & Management Company deployed $28.8M of net new capital in Q4 2016, opening 29 new positions and adding to 31 existing holdings. Its largest new stake was Waters Corp: 47,690 shares worth $6.41M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Gentex, an estimated $1.21M trimmed.

  • American Research & Management Company's largest Q4 2016 buy was Waters Corp: 47,690 shares worth $6.41M.
  • American Research & Management Company added most to KeyCorp in Q4 2016, an estimated $1.16M increase.
  • American Research & Management Company's biggest Q4 2016 reduction was Gentex, cutting an estimated $1.21M.
  • American Research & Management Company fully exited PIEDMONT NATURAL GAS CO INC(NC in Q4 2016, selling an estimated $105K.
  • American Research & Management Company's ten largest holdings make up 37% of its $292M portfolio in Q4 2016.
  • American Research & Management Company opened 29 new positions and closed 29 in Q4 2016.
  • American Research & Management Company's portfolio value rose 6.4% quarter-over-quarter to $292M.

Based on American Research & Management Company's 13F filing for Q4 2016, filed 31 Jan 2017.